Tounjian Advisory Partners Invests $1.28M in CVS Health

New stake in pharmacy operator's stock purchased during 3rd quarter

Mar. 3, 2026 at 7:07am

Got story updates? Submit your updates here. ›

Tounjian Advisory Partners LLC purchased a new stake of 16,936 shares in CVS Health Corporation (NYSE:CVS) during the 3rd quarter, valued at approximately $1,277,000. The investment comes as several other hedge funds and institutional investors have also recently bought and sold shares of the pharmacy operator.

Why it matters

CVS Health is one of the largest pharmacy chains in the United States, operating retail pharmacies, pharmacy benefit management services, and health care solutions. The investment by Tounjian Advisory Partners reflects ongoing investor interest in the company as it navigates the evolving healthcare landscape.

The details

According to a recent SEC filing, Tounjian Advisory Partners purchased the new stake in CVS Health during the 3rd quarter of 2026. The 16,936 shares were valued at around $1,277,000. Several other major institutional investors, including Vanguard Group, State Street Corp, and Geode Capital Management, have also been active in trading CVS Health stock.

  • Tounjian Advisory Partners purchased the new stake in CVS Health during the 3rd quarter of 2026.

The players

Tounjian Advisory Partners LLC

An investment management firm that purchased a new $1.28 million stake in CVS Health Corporation.

CVS Health Corporation

A large pharmacy operator and healthcare company that runs retail pharmacies, pharmacy benefit management services, and other healthcare solutions.

Got photos? Submit your photos here. ›

The takeaway

The investment by Tounjian Advisory Partners in CVS Health reflects ongoing institutional interest in the pharmacy and healthcare company as it navigates industry changes. CVS Health's diversified business model and market position continue to attract attention from major investors.